Clinical Trials, TCGA: Deep Integrative Research RT, Imaging, Pathology, “omics” Joel Saltz MD, PhD Director Center for Comprehensive Informatics.

Slides:



Advertisements
Similar presentations
CVRG Presenter Disclosure Information Joel Saltz MD, PhD Director Comprehensive Informatics Center Emory University Translational Research Informatics.
Advertisements

CIP NCIA Rembrandt – Vasari Project research enabled by caBIG - NCIA Eliot Siegel.
Pathology and Imaging In Biomarker Development C. Carl Jaffe, MD, FACC Cancer Imaging Program National Cancer Institute.
Enterprise Use Cases. Levels LevelDescriptionExamples 0 0aVerbal CommunicationNon-permanent, e.g. verbal communication 1Non-electronic dataMail, phone.
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
In Silico Brain Tumor Research Center Emory University, Atlanta, GA Classification of Brain Tumor Regions S. Cholleti, *L. Cooper, J. Kong, C. Chisolm,
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
Introduction Integrative Analysis of Genomic Variants in Carcinogenesis Syed Haider, Arek Kasprzyk, Pietro Lio Artificial Intelligence and Computational.
RSNA 2010 Talking Points NCI had two booths: The caBIG exhibit which comprised of seven workstations showcasing the NBIA, AIM, Virtual PACS, AVT, XIP,
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
CORRELATIO NAL RESEARCH METHOD. The researcher wanted to determine if there is a significant relationship between the nursing personnel characteristics.
CaGrid, Fog and Clouds Joel Saltz MD, PhD Director Center for Comprehensive Informatics.
Genetic Alterations of TP53 Gene in Brain Astrocytic Tumours Methodology Θ Eighty-three brain tumor biopsies were collected and used in this study. Thirty.
CS 548 Spring 2015 Showcase by Pankaj Didwania, Sarah Schultz, Mingchen Xie Showcasing Work by Malhotra, Chau, Sun, Hadjipanayis, & Navathe on Temporal.
Integrative Analysis of Pathology, Radiology and High Throughput Molecular Data Joel Saltz MD, PhD Director Center for Comprehensive Informatics.
Integrative Analysis of Pathology, Radiology and High Throughput Molecular Data Joel Saltz MD, PhD Director Center for Comprehensive Informatics.
Imaging Genomics: Correlation of Invasive Genomic Composition and Patient Survival Using Qualitative and Quantitative MR Imaging Parameters RR Colen 1,
Imaging Workspace An Overview and Roadmap Eliot L. Siegel, MD Imaging Workspace Lead SME January 23, 2008.
Kerrington Smith, M.D. CTOS Nov 14, 2008
Radiogenomics in glioblastoma multiforme
1 Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems Max Robinowitz, MD.
Data Analysis Summary. Elephant in the room General Comments General understanding that informatics is integral in medical sequencing and other –omics.
1 Jack London, PhD Research Professor, Cancer Biology Thomas Jefferson University Informatics Shared Resource Director Sidney Kimmel Cancer Center at Jefferson.
Department of Radiology and Imaging Sciences Division of Neuroradiology University School of Medicine.
Prediction of Glioblastoma Multiforme Patient Time to Recurrence Using MR Image Features and Gene Expression Nicolasjilwan, M.1·Clifford, R.2·Flanders,
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
© NlH National Center for Image Guided Therapy, 2012 ASNR 2012 Imaging Genomic mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme.
Nadir Saghar, Tony Pan, Ashish Sharma REST for Data Services.
May 2007 Mouse GBM: A Pilot Collection on NBIA Sunny Jansen Postdoctoral Fellow Terry Van Dyke Lab Mouse Cancer Genetics Program NCI Collaboration with.
ASNR 2012 Methodology for Imaging Genomics of Gliomas
1 Introduction and Welcome Joel Saltz MD, PhD Co-Director caGrid Knowledge Center caGrid Knowledge Center Workshop February 2011.
The Use of Predictive Biomarkers in Clinical Trial Design Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute
Prediction of Glioblastoma Multiforme Patient Survival Using MR Image Features and Gene Expression Control/Tracking Number: 11-O-1519-ASNR Nicolasjilwan,
Structural Models Lecture 11. Structural Models: Introduction Structural models display relationships among entities and have a variety of uses, such.
BBN Technologies Copyright 2009 Slide 1 The S*QL Plugin for Cytoscape Visual Analytics on the Web of Linked Data Rusty (Robert J.) Bobrow Jeff Berliner,
ICNCT-16, June 2014, Helsinki Glioma heterogeneity and the L-Amino acid transporter-1 (LAT1): A first step to stratified BPA-based BNCT? D. Ngoga 1 ; C.
Introduction to caIntegrator caBIG ® Molecular Analysis Tools Knowledge Center April 3, 2011.
A comparative study of survival models for breast cancer prognostication based on microarray data: a single gene beat them all? B. Haibe-Kains, C. Desmedt,
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Jin MENG Shen FU (DPD 08) Biology 2 - Head/Neck and CNS Tumors
Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.
CBioPortal Web resource for exploring, visualizing, and analyzing multidimentional cancer genomics data.
Clinical and Translational Imaging Informatics Project Coordination Meeting April 15, 2015.
Imaging Workspace An Overview and Roadmap Eliot L. Siegel, MD Imaging Workspace Lead SME January 23, 2008.
Advances and challenges in computational modeling and statistical learning of biological systems Qi Liu Department of Biomedical Informatics Vanderbilt.
The Contribution of caBIG and In Silico Resources to Glioblastoma Research Daniel J. Brat MD, PhD Department of Pathology and Laboratory Medicine Emory.
CTTI PROJECT Emory University, Quality Assurance and Review Center (QARC) and Washington University in St. Louis.
Department of Pathology UC Davis School of Medicine Jeff Gregg, M.D. The Development of an Informatics Platform for the Characterization of Clinical Samples.
PD: Joel Saltz, MD, PhD PI: Daniel J. Brat MD, PhD Emory University School of Medicine In Silico Center for Brain Tumor Research.
Pichai Raman on behalf of cBioPortal Team Wednesday, May 25, 16
TMIST A Breast Cancer Screening Trial
miRNA-targets cross-talks: key players in glioblastoma multiforme
Mouse GBM: A Pilot Collection on NBIA
A graph-based integration of multiple layers of cancer genomics data (Progress Report) Do Kyoon Kim 1.
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Department of Laboratory Medicine, CORE Diagnostics, Gurgaon, India
CLASSIFICATION OF TUMOR HISTOPATHOLOGY VIA SPARSE FEATURE LEARNING Nandita M. Nayak1, Hang Chang1, Alexander Borowsky2, Paul Spellman3 and Bahram Parvin1.
MR images analysis of glioma
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Joel Saltz MD, PhD Director Center for Comprehensive Informatics
Treatment Overview: The Multidisciplinary Team
Why study Brain tumour Biology???
Volume 5, Issue 6, Pages e3 (December 2017)
Volume 143, Issue 3, Pages e2 (September 2012)
Integration of Genomic Medicine into Pathology Residency Training
CSC 578 Neural Networks and Deep Learning
Neuropathology at Southmead
Using clinical trial data as real-world evidence
Presentation transcript:

Clinical Trials, TCGA: Deep Integrative Research RT, Imaging, Pathology, “omics” Joel Saltz MD, PhD Director Center for Comprehensive Informatics

Will Treatment work and if not, why not? Example: Avastin and Glioblastoma in RTOG-0825 Treatment: Radiation therapy and Avastin (anti angiogenesis) Predict and Explain: Genetic, gene expression, microRNA, Pathology, Imaging RT, imaging, Pathology markup/annotations

Avastin and GBMs in RTOG-0825 Analysis on pre-treatment tissue to extract imaging and molecular biomarkers that are indicative of Outcome/Avastin response. whole genome mRNA and microRNA expression profiling of GBM tumor specimens to identify outcome/Avastin response biomarkers Analyzing the Pathology imaging and diagnostic imaging registered with the therapy plan to extract any biomarkers that can indicate Avastin response. Does advanced imaging (eg: diffusion weighted imaging) provide markers that can predict patient response? RT, Diagnostic Imaging and Pathology: Tools to support Human/Algorithm analyses, annotation, markup (extensions of AIM) Data management and display framework that integrates the pathology with the radiology, therapy treatment information and the clinical data. This involves integrating platforms that manage imaging data at ACRIN, pathology at UCSF and molecular data from Emory.

For the sake of quality control, reproducibility and data sharing, results of RT, imaging, Pathology observations and analyses need to be described in a well defined manner Finding: mass Mass ID: 1 Margins: spiculated Length: 2.3cm Width: 1.2cm Cavitary: Y Calcified: N Spatial relationships: Abuts pleural surface; invades aorta

Distinguish (and maybe redefine) astrocytic, oligodendroglial and oligoastrocytic tumors using TCGA and Rembrandt Important since treatment and Outcome differ Link nuclear shape, texture to biological and clinical behavior How is nuclear shape, texture related to gene expression category defined by clustering analysis of Rembrandt data sets? Relate nuclear morphometry and gene expression to neuroimaging features (Vasari feature set) Genetic and gene expression correlates of high resolution nuclear morphometry and relation to MR features using Rembrandt and TCGA datasets.

Annotation and Markup of Pathology Data needs Human/Algorithm Cooperation Astrocytoma vs Oligodendroglima TCGA finds genetic, gene expression overlap Pathologists have also long seen overlap Relationship between Pathology, Molecular, Radiology Relationship to Outcome, treatment response

What you find depends on where you look GBM gene expression patterns will be influenced by necrosis, degree and type of angiogenesis Degree and pattern of necrosis/angiogenesis varies within a given tumor so molecular analyses need to be interpreted in the context of what was sampled

Use of randomly selected sample to determine whether the earth is wet or dry …

Prediction using Rembrandt/TCGA Matched sets of cases where low grade gliomas progressed to Glioblastoma Multiforme Examine the gene expression profile of low grade gliomas that progress to GBM for predictive clustering, prognostic significance and correlates with pathologic and radiologic features. investigate the gene expression profiles, pathologic properties and MR imaging characteristics of low grade astrocytomas and the GBMs that have progressed from them within the Rembrandt data set. Determine if gene expression profiles of the low grade gliomas cluster closely with any one of the gene cluster families represented in the TCGA analysis or are more evenly distributed

Link Radiology to Pathology, Molecular “Ground Truth” Identify correlates of MRI enhancement patterns in astrocytic neoplasms with underlying vascular changes and gene expression profiles. Better understanding of the relation of enhancement patterns to histologic features and grade would facilitate the ability to prognosticate and devise treatment strategies non-invasively based on neuroimaging findings. Define the precise relationship between imaging characteristics related to contrast-enhancement and those seen by advanced imaging sequences with the underlying histopathologic features, especially those associated with vascular changes Correlate specific MR characteristics defined by the Vasari Feature Set with pathologic grade, vascular morphology and underlying gene expression profiles

TCGA. Rembrandt, Vasari

Annotation Markup, Tools, Metadata Management, Query Annotation/Markup for RT, standard MR and advanced imaging, Pathology Importance of many features will be determined via research so in some cases we need ad-hoc shared annotation/markup schemes Human/algorithm interaction plays key role in Pathology, advanced imaging and likely RT Multiple platforms will be needed to support human/algorithm annotation and markup – leverage XIP, caMicroscope, GridImage etc

Summary Semantic query to pose questions involving annotation/markup (e.g. IQ project) Grid based metadata management – AIM server, NBIA and more Consistent scheme for defining and enforcing data level security across grid-distributed data sources Grid based auditing Workflow (taverna, wings etc)